VOD vs GSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

VOD

48.1
AI Score
VS
GSK Wins

GSK

52.2
AI Score

Investment Advisor Scores

VOD

48score
Recommendation
HOLD

GSK

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric VOD GSK Winner
Forward P/E 35.5872 9.7656 GSK
PEG Ratio 0.6057 6.1023 VOD
Revenue Growth 7.3% 5.3% VOD
Earnings Growth -15.4% -69.5% VOD
Tradestie Score 48.1/100 52.2/100 GSK
Profit Margin -1.0% 14.5% GSK
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

VOD 1M: +3.9% · 3M: +27.7% GSK 1M: -6.9% · 3M: -11.6%

Current Technical Phase

VOD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.7% over 20 days), RSI 52

RSI (14): 52.4 · Price: $16.70

GSK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 34

RSI (14): 33.5 · Price: $46.96

Fundamentals Snapshot

Metric VOD GSK
Market Cap — —
Forward P/E 21.3 9.4
Trailing P/E — 15.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.3% 0.7%
Operating Margin 0.1% 0.3%
EPS -0.14 3.12
Dividend Yield 0.03% 0.04%

Frequently Asked Questions

Based on our detailed analysis, GSK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.